Population prevalence of Down's syndrome in the United Kingdom
Alexander, M., Ding, Y., Foskett, N., Petri, H., Wandel, C., Khwaja, O.
Published in Journal of intellectual disability research (01.09.2016)
Published in Journal of intellectual disability research (01.09.2016)
Get full text
Journal Article
Increased drug delivery to the brain by P-glycoprotein inhibition
Sadeque, A J, Wandel, C, He, H, Shah, S, Wood, A J
Published in Clinical pharmacology and therapeutics (01.09.2000)
Published in Clinical pharmacology and therapeutics (01.09.2000)
Get more information
Journal Article
The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors
Kim, R B, Fromm, M F, Wandel, C, Leake, B, Wood, A J, Roden, D M, Wilkinson, G R
Published in The Journal of clinical investigation (15.01.1998)
Published in The Journal of clinical investigation (15.01.1998)
Get full text
Journal Article
First-in-man study with a novel PEGylated recombinant human insulin-like growth factor-I
Kletzl, H, Guenther, A, Hoeflich, A, Hoeflich, C, Frystyk, J, Staack, R.F, Schick, E, Wandel, C, Bleich, N, Metzger, F
Published in Growth hormone & IGF research (01.04.2017)
Published in Growth hormone & IGF research (01.04.2017)
Get full text
Journal Article
P.1.g.041 RG1662, a new negative allosteric modulator of the gamma-aminobutyric acid Aα5 receptor subtype, does not show convulsions at relevant doses
Wandel, C, Thomas, A, Hernandez, M.C, Ballard-Yardy, T, Knoflach, F, Trube, G, Rothfuss, A, Husar, E, Lennon-Chrimes, S, Bentley, D, d'Ardhuy, X. Liogier, Squassante, L, Noeldeke, J, Khwaja, O
Published in European neuropsychopharmacology (01.09.2015)
Published in European neuropsychopharmacology (01.09.2015)
Get full text
Journal Article
Midazolam is metabolized by at least three different cytochrome P450 enzymes
WANDEL, C., BÖCKER, R., BÖHRER, H., BROWNE, A., RÜGHEIMER, E., MARTIN, E.
Published in British Journal of Anaesthesia (01.11.1994)
Published in British Journal of Anaesthesia (01.11.1994)
Get full text
Journal Article
Conference Proceeding
Mibefradil Is a P-Glycoprotein Substrate and a Potent Inhibitor of Both P-Glycoprotein and CYP3A In Vitro
WANDEL, C, KIM, R. B, GUENGERICH, F. P, WOOD, A. J. J
Published in Drug metabolism and disposition (01.08.2000)
Get full text
Published in Drug metabolism and disposition (01.08.2000)
Journal Article
Flexibility in a Crisis: How Strong Relational Coordination and Lean Literacy Helped Us Weather the COVID Storm
Sulmonte, Kimberlyann, Bourie, Patricia Q, Carnevale, Kerry, Clark, Lauren T S, Joseph, Bridgid G, Midura, Michelle, Wandel, Jane C, Maurer, Marsha L
Published in Nursing administration quarterly (01.10.2022)
Published in Nursing administration quarterly (01.10.2022)
Get more information
Journal Article
P42 Practical considerations for delandistrogene moxeparvovec gene therapy in patients with Duchenne muscular dystrophy
Mendell, J., Proud, C., Zaidman, C., Mason, S., Darton, E., Wandel, C., Murphy, A., Mercuri, E., Muntoni, F., McDonald, C.
Published in Neuromuscular disorders : NMD (01.10.2023)
Published in Neuromuscular disorders : NMD (01.10.2023)
Get full text
Journal Article
Relationship between Hepatic Cytochrome P450 3A Content and Activity and the Disposition of Midazolam Administered Orally
Wandel, C, Böcker, R H, Böhrer, H, deVries, J X, Hofmann, W, Walter, K, Kleingeist, B, Neff, S, Ding, R, Walter-Sack, I, Martin, E
Published in Drug metabolism and disposition (01.02.1998)
Get full text
Published in Drug metabolism and disposition (01.02.1998)
Journal Article
P54 T-cell response to SRP-9001 dystrophin transgene in a patient treated with Delandistrogene Moxeparvovec: a case of immune-mediated myositis
Khan, S., Haegel, H., Hollenstein, A., Wandel, C., Wagner, K., Asher, D., Griffin, D., Potter, R., Moeller, I., Singh, T., Rodino-Klapac, L.
Published in Neuromuscular disorders : NMD (01.10.2023)
Published in Neuromuscular disorders : NMD (01.10.2023)
Get full text
Journal Article
P47 ENVISION, a phase 3, randomized trial evaluating the safety and efficacy of delandistrogene moxeparvovec in Duchenne muscular dystrophy: study design
Muntoni, F., Mercuri, E., McDonald, C., Desguerre, I., Tulinius, M., Proud, C., Furgerson, M., Murphy, A., De Ford, C., Feng, T., Reid, C., Wandel, C., Shelton, N.
Published in Neuromuscular disorders : NMD (01.10.2023)
Published in Neuromuscular disorders : NMD (01.10.2023)
Get full text
Journal Article
P.210 Safety, tolerability, pharmacokinetics and metabolism of balovaptan, a selective vasopressin 1a receptor antagonist, in healthy subjects
Derks, M., Lennon-Chrimes, S., Guenther, A., Squassante, L., Wandel, C., Paehler, A., Kletzl, H.
Published in European neuropsychopharmacology (01.12.2019)
Published in European neuropsychopharmacology (01.12.2019)
Get full text
Journal Article
P41 EMBARK, a Phase 3 trial evaluating safety and efficacy of delandistrogene moxeparvovec in DMD: study design and baseline characteristics
Muntoni, F., Mercuri, E., Schara-Schmidt, U., Komaki, H., Richardson, J., Singh, T., Guridi, M., Mason, S., Murphy, A., Yu, L., Reid, C., Darton, E., Wandel, C., Mendell, J.
Published in Neuromuscular disorders : NMD (01.10.2023)
Published in Neuromuscular disorders : NMD (01.10.2023)
Get full text
Journal Article
P.128 Integrated analyses of data from clinical trials of delandistrogene moxeparvovec in DMD
Zaidman, C., Shieh, P., Proud, C., McDonald, C., Day, J., Mason, S., Guridi, M., Hu, L., Yu, L., Reid, C., Darton, E., Wandel, C., Richardson, J., Malhotra, J., Singh, T., Rodino-Klapac, L., Mendell, J.
Published in Neuromuscular disorders : NMD (01.10.2022)
Published in Neuromuscular disorders : NMD (01.10.2022)
Get full text
Journal Article
P.129 One-year data from ENDEAVOR, a phase 1b trial of delandistrogene moxeparvovec in boys with DMD
Zaidman, C., Proud, C., McDonald, C., Mason, S., Guridi, M., Wang, S., Reid, C., Darton, E., Wandel, C., Lewis, S., Malhotra, J., Griffin, D., Potter, R., Rodino-Klapac, L., Mendell, J.
Published in Neuromuscular disorders : NMD (01.10.2022)
Published in Neuromuscular disorders : NMD (01.10.2022)
Get full text
Journal Article